Company Filing History:
Years Active: 2000-2004
Title: Jhon Santiago Mejia: Innovator in Immunodiagnosis
Introduction
Jhon Santiago Mejia is a notable inventor based in Medellin, Colombia. He has made significant contributions to the field of immunodiagnosis, particularly in relation to heartworm infections in mammals. With a total of 2 patents, his work is recognized for its potential impact on veterinary medicine.
Latest Patents
One of Mejia's latest patents involves the discovery of a 31-33 kDa glycoprotein known as DiT33. This glycoprotein is a member of the family of putative pepsin inhibitors, which includes other known members such as Ov33, Bm33, and Av33. The invention outlines the use of DiT33 or Ov33 in the form of recombinant fusion or non-fusion proteins to monitor antibody responses. These responses can be utilized in the immunodiagnosis of heartworm infections in mammals. Additionally, antibodies reactive with DiT33 or Ov33 can be employed to detect the DiT33 antigen, further aiding in the diagnosis of heartworm infections.
Career Highlights
Jhon Santiago Mejia is currently employed at New England Biolabs, Inc., where he continues to advance his research and innovations. His work is pivotal in developing diagnostic tools that can improve the health and well-being of animals affected by heartworm.
Collaborations
Some of his notable coworkers include Francine B Perler and XiaQiang Hong. Their collaborative efforts contribute to the ongoing research and development in the field of immunodiagnosis.
Conclusion
Jhon Santiago Mejia's contributions to the field of immunodiagnosis, particularly through his patents, highlight his role as an innovator in veterinary medicine. His work has the potential to significantly enhance the diagnosis and treatment of heartworm infections in mammals.